Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacogenomic testing and prescribing patterns for patients with cancer in a large national precision medicine cohort. | J Med Genet | 2023 | 34872990 | PubTator, text mining | PubMed |
| Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a DPYD variant and decreased dihydropyrimidine dehydrogenase enzyme activity. | J Oncol Pharm Pract | 2023 | 34797200 | PubTator, text mining | PubMed |
| Expression characteristics of circular RNA in human traumatic brain injury. | Front Neurol | 2022 | 36712438 | PubTator, text mining | PubMed |
| Kidney tonifying traditional Chinese medicine: Potential implications for the prevention and treatment of osteoporosis. | Front Pharmacol | 2022 | 36699069 | PubTator, text mining | PubMed |
| CAR-T therapy followed by allogeneic hematopoietic stem cell transplantation for refractory/relapsed acute B lymphocytic leukemia: Long-term follow-up results. | Front Oncol | 2022 | 36686744 | PubTator, text mining | PubMed |
| Expanding the toolbox of metabolically stable lipid prodrug strategies. | Front Pharmacol | 2022 | 36686712 | PubTator, text mining | PubMed |
| Comprehensive analysis of hypoxia-related genes for prognosis value, immune status, and therapy in osteosarcoma patients. | Front Pharmacol | 2022 | 36686667 | PubTator, text mining | PubMed |
| Association Studies in Clinical Pharmacogenetics. | Pharmaceutics | 2022 | 36678742 | PubTator, text mining | PubMed |
| Benefit of Uracil-Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer. | Medicina (Kaunas) | 2022 | 36676634 | PubTator, text mining | PubMed |
| Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out. | Genes (Basel) | 2022 | 36672796 | PubTator, text mining | PubMed |
| A study of gene variation in All-RAS wild-type metastatic colorectal cancer and its correlation with cetuximab. | J Gastrointest Oncol | 2022 | 36636055 | PubTator, text mining | PubMed |
| Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathway. | Front Pharmacol | 2022 | 36618921 | PubTator, text mining | PubMed |
| The effect of medication reconciliation on generating an accurate medication list in a pharmacogenomics practice. | Ann Transl Med | 2022 | 36618791 | PubTator, text mining | PubMed |
| Refinement of a pharmacogenomics app for dosing guidelines for oncology: findings from the usability evaluation. | Ann Transl Med | 2022 | 36618784 | PubTator, text mining | PubMed |
| Raltitrexed as a substitute for capecitabine in metastatic gastric cancer: a case report and literature review. | Ann Transl Med | 2022 | 36618781 | PubTator, text mining | PubMed |
| Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics. | Front Immunol | 2022 | 36618350 | PubTator, text mining | PubMed |
| How to Implement a Pharmacogenetics Service at your Institution. | J Am Coll Clin Pharm | 2022 | 36589694 | PubTator, text mining | PubMed |
| Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia. | JAMA Netw Open | 2022 | 36580335 | PubTator, text mining | PubMed |
| Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration. | Front Immunol | 2022 | 36569844 | PubTator, text mining | PubMed |
| Cancer informatics analysis indicates high CHAC2 associated with unfavorable prognosis in breast cancer. | Front Oncol | 2022 | 36568153 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=34